Transdermal Drug Delivery Systems Market Share and Growth Forecast by Regions 2022-2027

The global transdermal drug delivery systems market size reached US$ 6.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.36% during 2022-2027.

Market Outlook: 

Transdermal drug delivery systems involve a painless method of delivering drugs through the skin systematically. It is a preferred non-invasive alternative to the parenteral route and oral intravascular mode of drug delivery into the body. This method involves the penetration of drugs via the stratum corneum, which passes through the epidermis and dermis without the accumulation of drugs into the dermal layer of the skin. It is widely utilized for the treatment of chronic and acute illnesses as well as cosmetic therapies.

Growth Drivers: 

The global market is primarily driven by significant growth in the healthcare sector. Moreover, continual technological advancements across the industry, such as the introduction of iontophoresis that facilitates self-administration of drugs, are creating a positive outlook for the market. The rising investments by public and private firms to upgrade the existing healthcare infrastructure are also contributing to the market growth. Other factors, including the increasing preference for non-invasive treatments among the masses and extensive research and development (R&D) activities, are propelling the market growth further. 

Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.

Get a free sample PDF of the Transdermal Drug Delivery Systems Market Study

Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global transdermal drug delivery systems market has been studied in the report with the detailed profiles of the key players operating in the market.

Major Players Covered: 

• 3M Company
• Acrux Limited
• Boehringer Ingelheim International GmbH
• Hisamitsu Pharmaceutical Co. Inc.
• Lavipharm S.A.
• LEAD CHEMICAL Co. Ltd.
• Luye Pharma Group
• Nutriband Inc.
• Viatris Inc.

Key Market Segmentation:

The report has segmented the global transdermal drug delivery systems market on the basis of technology, application and region.

Breakup by Technology:

• Electroporation
• Radiofrequency
• Iontophoresis
• Microporation
• Thermal
• Mechanical Arrays
• Ultrasound
• Others

Breakup by Application:

• Central Nervous System
• Pain Management
• Cardiovascular
• Hormone
• Others

Geographical Analysis: 

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Inquire Before Buying: https://www.imarcgroup.com/request?type=report&id=3983&flag=F

The report covers the key players of the business including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Gross Margin Sales with an exhaustive investigation of the market’s competitive landscape and definite data on vendors and thorough subtleties of elements that will challenge the development of significant market vendors.

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St, Ste R

Sheridan, WY 82801, USA

Website: https://www.imarcgroup.com/

Email: [email protected]

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800